Gene: TSACC
Official Full Name: TSSK6 activating cochaperoneprovided by HGNC
Gene Summary: Enables protein-folding chaperone binding activity. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26789 | TSACC Knockout cell line (HeLa) | Human | TSACC | 1:3~1:6 | Negative | Online Inquiry |
KO26790 | TSACC Knockout cell line (HCT 116) | Human | TSACC | 1:2~1:4 | Negative | Online Inquiry |
KO26791 | TSACC Knockout cell line (HEK293) | Human | TSACC | 1:3~1:6 | Negative | Online Inquiry |
KO26792 | TSACC Knockout cell line (A549) | Human | TSACC | 1:3~1:4 | Negative | Online Inquiry |
TSACC Gene Knockout Cell Lines are genetically engineered cell models designed to specifically disrupt the function of the TSACC gene, which encodes a protein involved in critical cellular processes, including cell signaling, proliferation, and metabolic regulation. By utilizing CRISPR-Cas9 technology, these knockout cell lines provide researchers with invaluable tools for investigating the biological role of TSACC in various contexts, enabling comprehensive studies on its implications in diseases such as cancer or metabolic disorders.
The primary functional mechanism of the TSACC Gene Knockout Cell Lines revolves around the targeted deletion of the TSACC gene, leading to a loss of function of the associated protein. This disruption allows researchers to explore downstream effects on cellular pathways, providing insights into the gene's role in health and disease. Such models are crucial for unraveling complex biological mechanisms, testing therapeutic approaches, and validating potential drug targets.
The scientific importance of TSACC Gene Knockout Cell Lines extends into both research and clinical settings. In research, these cell lines enable the exploration of gene function and the study of phenotypic changes arising from gene loss. Clinicians may benefit from this product by using it to model disease conditions in vitro, leading to better understanding and potential treatments for diseases linked to TSACC disruption.
What sets TSACC Gene Knockout Cell Lines apart from traditional cell lines or other knockout models is their specificity and precision, thanks to the advanced editing capabilities of CRISPR-Cas9. This technology reduces off-target effects and improves the reliability of experimental outcomes. Furthermore, the availability of validated knocking-out constructs accelerates the research timeline, allowing scientists to obtain data more rapidly and effectively.
These knockout cell lines are invaluable resources for researchers and clinicians seeking to embark on innovative scientific inquiries. Their precision, coupled with the potential to contribute to critical advancements in medical research, makes them essential for those dedicated to understanding and addressing complex biological questions.
Our company boasts a robust background in genetic engineering and cell line development, ensuring that TSACC Gene Knockout Cell Lines are of the highest quality and rigorously tested for consistency and effectiveness in research applications. By choosing our product, you are assured of rigorous scientific standards and exceptional support for your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.